Multiple sclerosis: Association with the interleukin-1 gene family polymorphisms in the Turkish population

International Journal of Neuroscience

Volumn 123, Issue 10, 2013, Pages 711-718

  Isik, Nihal ^a   Arman, Ahmet ^b   Canturk, Ilknur Aydin ^a   Gurkan, Ajda Coker ^c   Candan, Fatma ^a   Aktan, Sule ^b   Erzaim, Nilufer ^b   Duz, Ozge Arici ^a   Aydin, Tugrul ^a   Turkes, Muzaffer ^a   List, Edward O ^d,e  

^a GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c ISTANBUL KULTUR UNIVERSITY   (Turkey)

^d OHIO UNIVERSITY   (United States)

^e OHIO UNIVERSITY   (United States)

Author keywords

Cytokine; Demyelinating disease; Genotype distribution; Interleukin 1

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ALLELES; CYTOKINES; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; TURKEY; YOUNG ADULT;

EID: 84884395005     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.795563     Document Type: Article

References (46)

1. Noseworthy JH, Lucchinetti C, RodriguezM,Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.
2. Turkboru U, Alp R, Sur H, Gul L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006;27:17-21. (Pubitemid 44114406)
3. Celik Y, Birgili O, Kiyat A, Guldiken B, Ozkan H, Yalmaz H, Saip S, Yandim-Kuscu D, SutlasN,Agaoglu J, UtkuU, Hayran O, Siva A. Prevalence of multiple sclerosis in the metropolitan area of Edirne City, Turkey. Balkan Med J 2011;28:193-6.
4. Dyment DA, Sadovnick AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet 1997;6:1693-8. (Pubitemid 27401612)
5. Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, Semana G, Cournu-Rebeix I, Lyon-Caen O, Fontaine B, American-French Multiple Sclerosis Genetics Group. A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 2004;75:1070-8. (Pubitemid 39532074)
6. Lundmark F,Duvefelt K, Iacobaeus E, Kockum I,Wallstrm E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007;39:1108-13. (Pubitemid 47340654)
7. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA, Pericak-Vance MA, Haines JL, Multiple Sclerosis Genetics Group. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007;39:1083-91. (Pubitemid 47340652)
8. Dinarello CA,Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
9. Hirsch EC, Hunot S, Damier P, Faucheux B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?. Ann Neurol 1998;44(Suppl1):S115-20. (Pubitemid 28423837)
10. Auron PE. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine & Growth Factor Rev 1998;9:221-37. (Pubitemid 29019708)
11. Huang J, Xie ZK, Lu RB, Xie ZF. Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis. Inflamm Res 2013;62:97-106.
12. Tarlow JK, Blakemore AI, Lennard A, Solari R, Huges HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics 1993;91: 403-4. (Pubitemid 23177503)
13. McDowell TL, Symons JA, Ploski R, Faire O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1994;38:221-8.
14. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at ?511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992;1:450.
15. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
16. Schrijver HM, Crusius JB, Uitdehaag BM, Garcee Gonzlez MA, Kostense PJ, Polman CH, Pe ñea AS. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 1999;52: 595-9. (Pubitemid 29075610)
17. Schrijver HM, Van As J, Crusius JB, Dijkstra CD, Uitdehaag BM. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Mediators Inflamm 2003;12:89-94. (Pubitemid 36783247)
18. BorzaniI, Tola MR, Caniatti L, Collins A, De Santis G, Luiselli D, Mamolini E, Scapoli C. The interleukin-1 cluster gene region is associated with multiple sclerosis in an Italian Caucasian population. Eur J Neurol 2010;17:930-8.
19. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD,Montalban X, O'Connor P, Sandberg-WollheimM, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the Mc-Donald criteria. Ann Neurol 2011;69:292-302.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
21. Arman A, Yalmaz B, Coker A, Inanc N, Direskeneli H. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms inTurkish patients with rheumatoid arthritis. Clin Exp Rheumatol 2006;24:643-8. (Pubitemid 46138795)
22. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995;45(Suppl 6):S16-21.
23. Matsuda M, Tsukada N, Miyagi K, Yanagisawa N. Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis. J Neurol Sci 1991; 102:100-4.
24. Imamura K, Suzumura A, Hayashi F, Marunouchi T. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 1993;87:281-5. (Pubitemid 23122221)
25. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-35.
26. Dinarello CA,Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
27. Dinerallo CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 2011;41:1203-17.
28. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008;226:10-18.
29. InoueM, Shinohara ML.NLRP3 inflammasome andMS/EAE. Autoimmune Diseases 2012;2013:1-8.
30. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. Journal of Immunology 1999;163:2403-9. (Pubitemid 29399158)
31. Inoue M, Williams KL, Oliver T, Vandenabeele P, Rajan JV, Miao EA, Mari L, Shinohara ML. Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Science Signaling 2012;5(225):1-17.
32. De Jong BA, Huizinga TW, Bollen EL, Uitdehaag BM, Bosma GP, van Buchem MA, Remarque EJ, Burgmans AC, Kalkers NF, Polman CH, Westendorp RG. Production of IL-1Ra and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 2002;126(1-2):172-9. (Pubitemid 34521742)
33. Carrol ED, Payton A, Payne D, Miyajima F, Chaponda M, Mankhambo LA, Banda DL, Molyneux EM, Cox H, Jacobson G, Carr DF, Molyneux ME, Stewart JP, Quinn JP, Hart CA, Ollier WE. The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1. J Immunol 2011;186:2329-35.
34. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002;13:323-40.
35. Huang WX, He B, Hillert J. An interleukin 1-receptorantagonist gene polymorphism is not associated with multiple sclerosis. J Neuroimmunol 1996;67:143-4. (Pubitemid 26252874)
36. Feakes R, Sawcer S, Broadley S, Coraddu F, Roxburgh R, Gray J, Clayton D, Compston A. Interleukin 1 receptor antagonist (IL-1Ra) in multiple sclerosis. J Neuroimmunol 2000;105:96-101. (Pubitemid 30125434)
37. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 2000;106:220-7. (Pubitemid 30256096)
38. Mirowska-Guzel D, Gromadzka G, Mach A, Czlonkowski A, Czlonkowska A. Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol 2011;236:87-92.
39. Sciacca FL, Ferri C, Vandenbroeck K, Veglia F, Gobbi C, Martinelli F, Franciotta D, Zaffaroni M, Marrosu M, Martino G, Martinelli V, Comi G, Canal N, Grimaldi LM. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology 1999;52: 1896-8. (Pubitemid 29260907)
40. De la Concha EG, Arroyo R, Crusius JB, Campillo JA, Martin C, Varela de Seijas E, Pe ñea AS, Claver LE, Fernandez-Arquero M. Combined effect of HLA-DRB1?1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 1997;80:172-8. (Pubitemid 28015338)
41. Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, KoKo C, Jones PW, Fryer AA, Strange RC, Thompson AJ, Hawkins CP. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. Neuroimmunol 2002;129:197-204. (Pubitemid 34879089)
42. Luomala M, Lehtimki T, Elovaara I, Wang X, Ukkonen M, Mattila K, Laippala P, Koivula T, Hurme M. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci 2001;185:123-7. (Pubitemid 32318517)
43. HurmeM, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998;28:2598-602. (Pubitemid 28362734)
44. Aggelakis K, Zacharaki F, Dardiotis E, Xiromerisiou G, Tsimourtou V, Ralli S, Gkaraveli M, Bourpoulas D, Rodopoulou P, Papadimitriou A, Hadjigeorgiou G. Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS. Neurol Sci 2010;31:253-7.
45. Harding KE, Liang K, Cossburn MD, Ingram G, Hirst CL, Pickersgill TP, Te Water Naude J, Wardle M, Ben-Shlomo Y, Robertson NP, et al. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2013;84:141-7.
46. Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006;5(4):343-54.